Anderson, K M <br/><br/>
Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention.  [electronic resource] 

 -  Journal of the American College of Cardiology  Jun 2001 
 - 2059-65 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0735-1097 
<br/><br/><label>Standard No.: </label>10.1016/s0735-1097(01)01290-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abciximab<br/>Antibodies, Monoclonal--therapeutic use<br/>Atherectomy, Coronary<br/>Coronary Disease--mortality<br/>Humans<br/>Immunoglobulin Fab Fragments--therapeutic use<br/>Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors<br/>Randomized Controlled Trials as Topic<br/>Stents<br/>Survival Analysis